Clinical trials, biotech research and drug discovery could all be accelerated by AI, industry experts say. But what does that mean for achieving the long-awaited medical breakthroughs people care about most, such as cancer treatments and therapies for rare diseases? Our guests explain how AI-driven medicines are moving closer to patients.
Featuring: Emily Fang (InFocus Therapeutics) and Servina Liu (Taiwan Biomedical Innovation Association)
Host: Divya Gopalan